About Cytori
Cytori is a publicly listed company based in San Diego (United States) founded in 1996. Adipose-derived regenerative cells are developed for treating scleroderma and osteoarthritis. Cytori has raised $4.34 million across 17 funding rounds from investors including SVB, NIH and Oxford Finance. Cytori has completed 1 acquisition, including Azaya Therapeutics. Cytori offers products and services including Health Technologies. Its focus areas include Life Sciences, Cell Therapy, Stem Cells and Progenitor Cells. Its legal entity is CYTORI THERAPEUTICS, INC. Its competitors include ViaCyte, Capricor Therapeutics and Neurona Therapeutics; 2 of its 3 listed competitors have raised funding.
Company details
Cytori Therapeutics develops cellular and regenerative therapeutics. The company develops therapies using adipose-derived regenerative cells (ADRCs), which are obtained from human adipose tissue via liposuction. As of Feb 2016, Cytoris lead candidate is in phase III US and EU trials for scleroderma-associated hand dysfunction. In addition, it has two other candidates in phase II trials for knee osteoarthritis and urinary incontinence, and another candidate in preclinical testing for cutaneous thermal injury. Also have completed clinical trials for Cytori cell therapy in patients with heart failure (due to ischemic heart disease) and myocardial infarction.
- Headquarters San Diego, United States
- Stage Public
- SectorsHealthcare
- Website cytori.com/Home.aspx
- Social LinkedIn X Facebook YouTube
- Legal Name Cytori Therapeutics, Inc.
- Total Equity Funding$4.34M (USD)
in 17 rounds
- Latest Funding Round$10M (USD), Post-IPO
Nov 2017
- InvestorsSVB
& 6 more
- Investments & Acquisitions
Products & Services of Cytori
Cytori offers a comprehensive portfolio of products and services, including Health Technologies.
Offers tools for health research and provider services worldwide
Apps and channels of Cytori
its YouTube channel Cytori Therapeutics Inc has 19 subscribers and 1 videos.
Videos from Cytori
The most watched videos on Cytori's YouTube channel, Cytori Therapeutics Inc (19 subscribers). Click a video to play it here.
More on Cytori Therapeutics Inc.
Funding Insights of Cytori
Cytori has successfully raised a total of $4.34M across 17 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.34M
- Total Rounds 17
- Last Round Post-IPO — $10M
- First Round $4.34M
(Nov 2002)
- Investors Count 7
Latest 10 of 17 funding rounds of Cytori with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | $10M | Post-IPO | – | – | – |
| Jun 2016 | $17.1M | Post-IPO | – | – | – |
| May 2015 | $17.7M | Debt – Conventional | – | – | |
| Oct 2014 | $13.5M | Post-IPO | – | – | – |
| Jun 2014 | $10M | Post-IPO | – | – | – |
| Nov 2013 | $12M | Post-IPO | – | – | |
| Jul 2013 | $27M | Debt – Conventional | – | – | |
| Sep 2011 | $5M | Debt – Conventional | – | – | |
| Jul 2011 | $6M | Post-IPO | – | – | |
| Jun 2010 | $20M | Debt – Conventional | – | – |
7 investors in total: 7 institutional.
Investors in Cytori
Cytori has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, NIH and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Capital is provided to smaller U.S. companies for growth. | seaside88.com | North Palm Beach, United States | ||
Develops innovative technologies for regenerative medicine applications. | 2013 | loremvascular.com | Singapore, Singapore | |
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States | |
Offers flexible financing and risk-sharing for healthcare industry assets globally. | 2015 | gehcfinance.com | Boston, United States | |
Provides consulting, sales, and leasing services for medical equipment. | 1992 | ghs-inc.co.jp | Suita, Japan | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for Cytori
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cytori
3 people are tracked at Cytori (3 in leadership).
| Name | Role | Group |
|---|---|---|
Marc H. Hedrick | President & CEO | Leadership |
Sandra Johnson | Executive Assistant to the President and CEO & VP Finance & CFO | Leadership |
Seijiro Shirahama | President, Asia-Pacific | Leadership |
Complete people profiles for Cytori
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytori
Cytori has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Azaya Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Liposomal formulations of small molecules for cancer therapy are developed. | azayatherapeutics.com | San Antonio, United States | 2003 | Jan 2017 | •••• |
Complete acquisition details for Cytori
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cytori
5 dated milestones of Cytori across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Cytori is founded.
- Funding First funding round of $4.3M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Azaya Therapeutics.
- Funding Latest funding round, Post-IPO, of $10.0M.
Competitors of Cytori
Cytori has 3 listed competitors in our database, 2 of them funded. They include ViaCyte, Capricor Therapeutics and Neurona Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viacyte.com | 1999 | San Diego, United States | $389.03M | 126 | Cell therapy for diabetes is developed from stem cells. | |
| capricor.com | 2005 | Los Angeles, United States | 62 | Regenerative medicine for cardiovascular disorders is developed using cell-based platforms. | ||
| neuronatherapeutics.com | 2008 | San Francisco, United States | $417.69M | 67 | Cell-based therapies are developed for intractable neurological diseases. |
Detailed competitors of Cytori
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cytori
The website of Cytori (cytori.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 141.8% vs previous month
Websites whose visitors overlap most with Cytori. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cytokinetics.com | 100% | 25.3K | #1,072,700 | View details | |
| cmedresearch.com | 92% | View details | |||
numoda.com | numoda.com | 92% | – | ||
| nektar.com | 92% | 19.6K | #959,308 | View details | |
afibhope.com | afibhope.com | 91% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Cytori
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
3 companies that operate in the same segment as Cytori (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytori
Complete news archive for Cytori
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytori
Cytori was founded in 1996 and raised its 1st funding round 6 years after it was founded.
Cytori is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Cytori is a funded company, having raised a total of $4.34M across 17 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $20M, raised on Nov 2002.
Cytori Therapeutics develops cellular and regenerative therapeutics. The company develops therapies using adipose-derived regenerative cells (ADRCs), which are obtained from human adipose tissue via liposuction. As of Feb 2016, Cytoris lead candidate is in phase III US and EU trials for scleroderma-associated hand dysfunction. In addition, it has two other candidates in phase II trials for knee osteoarthritis and urinary incontinence, and another candidate in preclinical testing for cutaneous thermal injury. Also have completed clinical trials for Cytori cell therapy in patients with heart failure (due to ischemic heart disease) and myocardial infarction.
Cytori's top competitors include Neurona Therapeutics, Capricor Therapeutics and ViaCyte.
Cytori offers Health Technologies.
Cytori has made 1 acquisition, including Azaya Therapeutics.
Cytori has 7 investors. Key investors include SVB, NIH, Oxford Finance, Lorem Vascular, and GE Healthcare Equipment Finance.
Cytori operates through Cytori Therapeutics, Inc..